Previous close | 0.580 |
Open | 0.580 |
Bid | 0.590 x N/A |
Ask | 0.610 x N/A |
Day's range | 0.580 - 0.610 |
52-week range | 0.470 - 1.760 |
Volume | |
Avg. volume | 264,063 |
Market cap | 298.091M |
Beta (5Y monthly) | 0.87 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.470 |
Earnings date | 28 Mar 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 1.09 |
On March 28, 2024, Broncus Medical (02216.HK) (the "Company" or "we" ) announced annual results for FY 2023.
Broncus(2216.HK) is pleased to announce that, on November 23 2023 Broncus Hangzhou (a whollyowned subsidiary of Broncus, as Transferee) has entered into the Equity Transfer Agreement with the shareholders of the Hangzhou Jingliang, to acquire 100% equity interest in it.